BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 18, 2002
View Archived Issues
Chest 2002: imatinib mesilate in pulmonary fibrosis
Read More
Cost savings reported in COPD patients treated with cilomilast
Read More
Omalizumab reported to be as safe as placebo in allergic asthma/rhinitis
Read More
COPD and severe burns, two potential new indications for oxandrolone
Read More
Cytos and Medarex collaborate for new drug targets in immunological diseases
Read More
New alphavbeta6 integrin antagonists in early development at Merck KGaA
Read More
Novel MMP inhibitors in AstraZeneca pipeline
Read More
Compounds that directly inhibit the androgen receptor discovered at Praecis
Read More
New beta3-adrenoceptor agonists covered by Asahi patent
Read More
Novel PDE7 inhibitors and their use in arthritis, asthma, etc.
Read More
ICAgen claims voltage-dependent KCOs for epilepsy, pain, anxiety, etc.
Read More
FDA advisory committee recommends approval of Pegasys in combination with Copegus
Read More
Merck KGaA and Grupo Vita announce manufacturing and licensing agreement for Eneas
Read More
AnorMED updates status of product development
Read More
Chemoprotective agent heads for clinical trials at ProMetic
Read More
New biotechnology company receives investment from BTG
Read More
New multiclade HIV vaccine holds promise for broad efficacy
Read More
Atorvastatin exerts beneficial clinical and immunomodulatory effects in animal models of MS
Read More
Albuleukin superior to rIL-2 in mouse model of metastatic melanoma
Read More
Microbially produced kappa opioid receptor antagonist identified by Japanese research group
Read More
Phase II trial of TNFerade initiated in patients with esophageal cancer
Read More
Label change for Biogen's Avonex approved
Read More
Scynexis and Roche collaborate to discover and develop agents for CNS and metabolic diseases
Read More
ChromaVision and NewBiotics to collaborate on cancer therapeutic development
Read More
Grant awarded for first clinical trial of squalamine in the treatment of prostate cancer
Read More
Cell Therapeutics earns milestone payment
Read More
Ligand restructures Avinza license and supply agreement
Read More